PRTA Q3 2021 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$512M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$139M+88545.9% YoY

Gross Profit

$121M87.1% margin

Operating Income

$109M78.5% margin

Net Income

$109M78.5% margin

EPS (Diluted)

$2.13

QoQ Revenue Growth

+131.7%

Cash Flow

Operating Cash Flow

$112M

Free Cash Flow

$112M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$633M

Total Liabilities

$142M

Stockholders' Equity

$490M

Cash & Equivalents

$600M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$139M	$157,000	+88545.9%
Gross Profit	$121M	-$21M	+665.0%
Operating Income	$109M	-$31M	+454.1%
Net Income	$109M	-$31M	+457.3%

Revenue Segments

Collaboration

$78M76%

Collaboration Program, US Rights

$25M24%